And Then You're Dead

The Autopsy / Case File · Overdose & Substance

The Settlement Money

More than $50 billion is landing in state and county bank accounts over 18 years, paid by the drug companies, distributors, and pharmacy chains found to have fueled the overdose crisis. The settlements say at least 85 percent of it has to go toward opioid-related efforts. Almost nothing in the settlements says who has to check.

A national tracking database built by KFF Health News, with Johns Hopkins Bloomberg School of Public Health and the nonprofit Shatterproof, has logged more than 10,500 examples of how state and local governments spent or committed opioid settlement funds through the end of 2024 — and found that only a handful of states have committed to detailed public reporting of all of it. Where independent auditors have actually looked, in Nashville and elsewhere, they've found governance too weak to verify whether millions of dollars went where the settlement required.

And Then You're Dead · September 2026 · 10 min read

Join the discussion →
A wooden gavel resting on a courtroom table, with a blurred stack of documents and courtroom benches in the background
The opioid settlements were negotiated in courtrooms, but the money is spent almost entirely outside them — county health departments, sheriff's offices, and state opioid abatement councils with little uniform requirement to report what they bought. Photo: Joe Gratz, CC0, via Wikimedia Commons.

Between 2021 and 2026, roughly a dozen major settlements resolved thousands of lawsuits filed by states, counties, cities, and tribes against opioid manufacturers, distributors, and retail pharmacy chains — Purdue Pharma and the Sackler family, Johnson & Johnson, the "Big Three" distributors (McKesson, Cardinal Health, AmerisourceBergen), Walmart, CVS, Walgreens, and others — for their role in flooding communities with prescription opioids that helped ignite the overdose epidemic. The combined total exceeds $50 billion, disbursed in annual payments stretched out over as long as 18 years rather than a single lump sum. It is, by a wide margin, the largest public health settlement in American history after the 1990s tobacco Master Settlement Agreement — and it is being spent under an oversight structure that is, in the words of one KFF Health News investigation, "next to no accountability."

10,500 Line Items, and Still Not the Whole Picture

To even see where the money is going, KFF Health News, in partnership with Johns Hopkins Bloomberg School of Public Health and Shatterproof, built what functions as the closest thing to a national ledger: a searchable database compiling government budget documents, public meeting minutes, spending reports, and open-records requests county by county. As of its most recent update, the database logs more than 10,500 discrete examples of settlement spending reported by state and local governments for actions taken or committed through the end of 2024 — and its own documentation is explicit that this "does not represent all opioid settlement expenditures." It is a floor, assembled by journalists doing the work no single federal or state agency is doing systematically, not a ceiling on the true total.

The settlements themselves set a spending floor, not a reporting floor: at least 85 percent of the money must go toward "opioid remediation" — treatment, prevention, recovery housing, naloxone distribution, and related uses drawn from a broad approved list. But enforcement of that 85 percent threshold is left largely to the settling companies and to state attorneys general, and KFF's reporting found that only a small number of states — around a dozen — have committed to the kind of detailed, itemized public reporting that would let an outside observer actually verify compliance. Some attorneys general told KFF Health News directly that tracking how the money gets spent once it leaves the settlement fund simply "wasn't their job." Legal experts interviewed for the same reporting were skeptical that the paying companies were doing any independent monitoring either — they have little financial incentive to police spending once the checks have cleared.

0
billion dollars in opioid settlement funds committed to states and localities, paid out over up to 18 years
0
states that have committed to detailed public reporting of all their opioid settlement spending, per KFF Health News reporting

What "Weak Governance" Looks Like Up Close

Nashville offers the clearest case study of what happens when someone actually audits the spending instead of just tracking it. Metro Nashville learned in 2022 that it would receive roughly $23 million in opioid settlement funds, administered through the Metro Public Health Department, with the first tranche of about $4 million beginning to move in 2024. When Metro's own Office of Internal Audit reviewed that spending, it found there was no established "governance or oversight structure" for the funds at all — no consistent framework for evaluating whether the opioid-abatement programs the money funded were actually working. Auditors also documented direct interference in their own review process: emails showed the program manager overseeing the opioid-related activities reviewing, editing, and directing staff on how to answer auditors' questions before those answers were submitted.

The audit's conclusion was blunt: opioid settlement funds generally appeared to be supporting legitimate, appropriate programs, but weak governance and poor financial controls made it impossible to actually verify that millions of dollars had been spent in accordance with what the settlements required. Nashville's response — under public pressure once the audit became known — was to consider shifting fund management out of the Public Health Department and into the city's Finance Department, and to build a public-facing "Opioid Settlement Transparency Dashboard." Those are the kinds of structural fixes accountability advocates have been asking every recipient jurisdiction to adopt voluntarily since the settlements began flowing in 2022. Most haven't been asked to, let alone required.

Weak governance and poor financial controls made it impossible to verify whether millions of dollars had actually been spent in accordance with settlement requirements — in a city whose own auditors went looking. Most jurisdictions never get looked at at all.

Where the Money Has Actually Gone

The KFF database's 10,500-plus logged examples span the full range the settlements permit: treatment beds, medication-assisted treatment programs, naloxone purchases, school prevention curricula, recovery housing, peer-support specialist salaries, and drug courts. But the same reporting has also surfaced spending that sits at the outer edge of "opioid remediation," or well outside it, in jurisdictions with looser oversight. Some law enforcement agencies have used settlement funds — alongside naloxone kits, which are a defensible use — to buy equipment like gun silencers and surveillance drones. In Louisiana, one state gave 20 percent of its entire opioid settlement allocation directly to sheriffs' offices, a category of spending KFF's reporting tracked county by county to see what it actually purchased. Local governments elsewhere have put settlement dollars toward community events with a looser connection to opioid remediation — concerts, "sock hops," even an MMA event — spending that a jurisdiction with a functioning oversight structure would have had to justify against the settlements' approved-use list and that, in many places, nobody was positioned to challenge.

None of this means most settlement money is being misspent — the balance of documented spending across the KFF database goes to treatment, prevention, and recovery infrastructure that maps directly onto what the litigation was originally about. The deeper problem the reporting keeps surfacing is structural: with Medicaid facing budget pressure in many states, health advocates and researchers have raised a specific worry that opioid settlement funds — intended as new, additional money for a crisis that state budgets weren't otherwise covering — could increasingly get used to plug ordinary state health-budget holes instead, a substitution effect that would be difficult to detect precisely because so few states report spending in enough detail to distinguish "new" opioid-response funding from "replaced" existing funding.

An 18-Year Clock With No Uniform Alarm

The settlement structure itself compounds the tracking problem. Because payments are staggered over as long as 18 years rather than delivered all at once, most jurisdictions are still receiving new tranches of money years after the first checks arrived in 2022 — which means any given county's "opioid settlement spending" figure at any moment is a moving target, and the pressure to spend quickly and visibly can work against the slower, harder-to-headline investments (workforce training for addiction counselors, long-term treatment infrastructure) that public health researchers generally consider more durable than one-time purchases. Every dollar disbursed without a matching public accounting is a dollar where the only verification that it went toward opioid remediation, rather than toward something a city council found politically convenient to fund that year, is whatever an outside journalist or an internal auditor happens to go looking for — and as Nashville's case shows, going looking is still the exception, not the rule, four years into the largest opioid-related payout in American history.

And Then You're Dead

The lawsuits took years to litigate and produced a number — $50 billion — precise enough to put in a headline. What happens to that number after it lands in a county bank account is, in most of the country, not tracked with anything like the same precision. The settlement bought a check. It didn't buy a receipt.

That's it. That's the whole thing.

Comments

Loading…

Comments are anonymous and moderated.

Sources